Resmed (RSMDF) Long-Term Deferred Tax (2010 - 2026)

Resmed (RSMDF) has reported Long-Term Deferred Tax for 17 consecutive years, with $329.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Long-Term Deferred Tax rose 30.08% year-over-year to $329.3 million; the trailing twelve-month figure through Jun 2026 stood at $329.3 million (up 30.08% YoY), and the FY2026 full-year result was $329.3 million, up 30.08% from the prior year.
• Long-Term Deferred Tax rose to $329.3 million in Q2 2026 per RSMDF's latest filing, from $312.6 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $329.3 million in Q2 2026 and bottomed at $74.8 million in Q1 2022.
• Historically, Long-Term Deferred Tax has averaged $184.1 million across 5 years, with a median of $182.8 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Long-Term Deferred Tax decreased 0.2% in 2022, then soared 81.8% in 2023.
• Over 5 years, Long-Term Deferred Tax stood at $85.8 million in 2022, then soared by 81.8% to $156.0 million in 2023, then surged by 34.3% to $209.4 million in 2024, then soared by 36.51% to $285.9 million in 2025, then gained by 15.16% to $329.3 million in 2026.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $329.3 million, $312.6 million, and $285.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.